DiseaseID 4452

慢性期髓系白血病

disease

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab

Disease: 1Symptom: 1Target: 12Links: 13

Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id: 4452
Core Entity Id: 60802
Source Entity Count: 1
Preferred Name: Leukemia, Myeloid, Chronic-Phase
Name Cn: 慢性期髓系白血病
Name Pinyin: Man Xing Qi Sui Xi Bai Xue Bing
Name En: Leukemia, Myeloid, Chronic-Phase
Name Latin
Bilingual Status: complete
Disease Type: disease
Umls Disease Type: Neoplastic Process
Disgenet Type: disease
Mesh Class: Neoplasms; Hemic and Lymphatic Diseases
Do Class
Hpo Class
Mesh Class Name: Neoplasms; Hemic and Lymphatic Diseases
Hpo Class Name
Do Class Name
Disease Definition: NCI2016_NCI-GLOSS_1602D:A phase of chronic myelogenous leukemia in which fewer than 10% of the cells in the blood and bone marrow are blast cells (immature blood cells). This phase may last from several months to several years, and there may be no symptoms of leukemia.|NCI2016_02D:A phase of chronic myelogenous leukemia in which the peripheral blood smear shows leukocytosis due mainly to neutrophils in different stages of maturation. Blasts usually account for less than 2% of the white blood cells counts. The platelet count is normal or increased. Thrombocytopenia is very uncommon during the chronic phase. Most patients have mild anemia. The bone marrow biopsy is hypercellular due to increased numbers of neutrophils and their precursors. Blasts usually account for fewer than 5% of the marrow cells, and more than 10% indicates transformation to the accelerated phase. Megakaryocytes are smaller than normal and have hypolobated nuclei. The spleen is enlarged due to infiltration of the cords of the red pulp by granulocytes. Most patients with chronic myelogenous leukemia are diagnosed in the chronic phase, which usually has an insidious onset and may last from several months to several years. (WHO, 2001)|MSH2017_2016_08_12:The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.
Version: v2
Suppressed: No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name

Leukemia, Myeloid, Chronic-Phase

Role

preferred

Cross References

Trusted external identifiers retained for this final record.

Herb

HBDIS001714

Me Sh

D015466

Umls

C0023474

Sym Map

SMDE10400

Dis Ge Net

C0023474

Umls Sty

T191

Me Sh Class

C04C15

Tcmbank Disease

4958

Attributes

Merged source attributes and domain-specific metadata.

Version

Suppress

Disease Type

disease

Umls Disease Type

Neoplastic Process

Disease Definition

NCI2016_NCI-GLOSS_1602D:A phase of chronic myelogenous leukemia in which fewer than 10% of the cells in the blood and bone marrow are blast cells (immature blood cells). This phase may last from several months to several years, and there may be no symptoms of leukemia.|NCI2016_02D:A phase of chronic myelogenous leukemia in which the peripheral blood smear shows leukocytosis due mainly to neutrophils in different stages of maturation. Blasts usually account for less than 2% of the white blood cells counts. The platelet count is normal or increased. Thrombocytopenia is very uncommon during the chronic phase. Most patients have mild anemia. The bone marrow biopsy is hypercellular due to increased numbers of neutrophils and their precursors. Blasts usually account for fewer than 5% of the marrow cells, and more than 10% indicates transformation to the accelerated phase. Megakaryocytes are smaller than normal and have hypolobated nuclei. The spleen is enlarged due to infiltration of the cords of the red pulp by granulocytes. Most patients with chronic myelogenous leukemia are diagnosed in the chronic phase, which usually has an insidious onset and may last from several months to several years. (WHO, 2001)|MSH2017_2016_08_12:The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.

Me Sh Disease Class

Neoplasms; Hemic and Lymphatic Diseases

Dis Ge Net Disease Type

disease

Disease Class Name Me Sh

Neoplasms; Hemic and Lymphatic Diseases

Umls Semantic Type Name

Neoplastic Process